Home › Asset managers › Compare 2025-2026 › JPMorgan vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
JPMorgan 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 30,437 | 24,523 | 1,668 | 4,246 | 93.6% | 88.3% |
| Board proposals | 24,375 | 19,281 | 1,523 | 3,571 | 92.7% | 87.6% |
| E&S shareholder proposals | 144 | 7 | 0 | 137 | 100.0% | 43.7% |
| Other items | 5,918 | 5,235 | 145 | 538 | 97.3% | 92.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
3,571 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | JPMorgan | Brighthouse |
|---|---|---|---|---|---|---|
| AMRIZE AG | April 21, 2026 | Re-election of Jan Jenisch as Chairman of the Board Corporate Governance |
Board | For | FOR 3 funds |
Split 2 FOR, 2 AGAINST |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF MARTIN J. BARRINGTON AS RESTRICTED SHARE DIRECTOR AND ELECT WILLIAM F. GIFFORD, JR. AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 6 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | ACKNOWLEDGE RESIGNATION OF SALVATORE MANCUSO AS RESTRICTED SHARE DIRECTOR AND ELECT JENNIFER HUNTER AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 6 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | AUTHORIZE REPURCHASE OF UP TO 20 PERCENT OF ISSUED SHARE CAPITAL Capital Structure |
Board | For | AGAINST 6 funds |
Split 1 FOR, 2 AGAINST |
| ANHEUSER-BUSCH INBEV SA/NV | April 29, 2026 | REELECT ALEJANDRO SANTO DOMINGO AS RESTRICTED SHARE DIRECTOR Director Elections |
Board | For | AGAINST 6 funds |
Split 1 FOR, 2 AGAINST |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the Amended and Restated 2022 Stock Incentive Plan. Compensation |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| ANI PHARMACEUTICALS, INC. | May 21, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Advisory approval of the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
Split 3 FOR, 2 ABSTAIN |
| ANNALY CAPITAL MANAGEMENT, INC. | June 10, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 3 FOR, 2 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Midstream Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO MIDSTREAM CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Midstream Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 3 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To approve, on an advisory basis, the compensation of Antero Resources Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 1 ABSTAIN |
| ANTERO RESOURCES CORPORATION | June 3, 2026 | To ratify the appointment of KPMG LLP as Antero Resources Corporation's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 1 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board or the Audit Committee of the Board to determine the remuneration of Ernst & Young Ireland, in its capacity as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 20 funds |
Split 9 FOR, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Authorize the Board to issue Class A Ordinary Shares under Irish Law. Capital Structure |
Board | For | FOR 20 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Authorize the Board to opt-out of statutory pre-emption rights under Irish Law. Capital Structure |
Board | For | FOR 20 funds |
Split 9 FOR, 2 AGAINST |
| AON PLC | June 26, 2026 | Ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 20 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| AON PLC | June 26, 2026 | Re-appoint Ernst & Young Chartered Accountants as the Company's statutory auditor under Irish Law. Audit-related |
Board | For | FOR 20 funds |
Split 8 FOR, 1 AGAINST, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Advisory vote to approve the compensation of APA's named executive officers Say-on-Pay |
Board | For | AGAINST 7 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Approval of an amendment to APA's 2016 Omnibus Compensation Plan to extend its term and increase the shares authorized for issuance thereunder Compensation |
Board | For | FOR 5 funds |
Split 5 FOR, 2 ABSTAIN |
| APA CORPORATION | May 21, 2026 | Ratification of appointment of Ernst & Young LLP as APA's independent auditor Audit-related |
Board | For | FOR 5 funds |
Split 5 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | Election of Director for a one-year term expiring at the 2027 Annual Meeting of Shareholders: Sir Martin E. Franklin Director Elections |
Board | For | FOR 5 funds |
Split 2 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 9 FOR, 2 ABSTAIN |
| API GROUP CORPORATION | May 15, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the 2026 fiscal year. Audit-related |
Board | For | FOR 5 funds |
Split 9 FOR, 2 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 7 funds |
Split 6 FOR, 3 ABSTAIN |
| APOGEE THERAPEUTICS, INC. | June 9, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 3 ABSTAIN |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | Election of Director for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc Beilinson Director Elections |
Board | For | FOR 9 funds |
Split 1 FOR, 1 ABSTAIN |
| APOLLO GLOBAL MANAGEMENT, INC. | June 8, 2026 | The ratification of the appointment of Deloitte & Touche LLP as AGM's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 9 funds |
Split 4 FOR, 1 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| APPFOLIO, INC. | June 12, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Approval on an advisory basis of executive compensation paid by the Company. Say-on-Pay |
Board | For | FOR 6 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLE HOSPITALITY REIT, INC. | May 22, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm to serve for 2026. Audit-related |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLIED OPTOELECTRONICS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 1 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
Split 4 FOR, 4 AGAINST, 3 ABSTAIN |
| APPLOVIN CORPORATION | June 3, 2026 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 22 funds |
Split 8 FOR, 3 ABSTAIN |
| APTARGROUP, INC. | May 6, 2026 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 ABSTAIN |
| APTARGROUP, INC. | May 6, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| APTIV PLC | April 29, 2026 | Proposal to re-appoint auditors, ratify independent public accounting firm and authorize the directors to determine the fees paid to the auditors. Audit-related |
Board | For | FOR 12 funds |
Split 5 FOR, 2 ABSTAIN |
| APTIV PLC | April 29, 2026 | Say-on-Pay - To approve, by advisory vote, executive compensation. Say-on-Pay |
Board | For | AGAINST 16 funds |
Split 5 FOR, 2 ABSTAIN |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 4 funds |
Split 1 FOR, 2 AGAINST, 2 ABSTAIN |
| ARCBEST CORPORATION | April 24, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 5 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCBEST CORPORATION | April 24, 2026 | To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCH CAPITAL GROUP LTD | May 5, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 21 funds |
Split 8 FOR, 2 ABSTAIN |
| ARCH CAPITAL GROUP LTD. | May 5, 2026 | To appoint PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 17 funds |
Split 8 FOR, 2 ABSTAIN |
| ARCHER AVIATION INC. | June 26, 2026 | Approval of the redomestication of the Company from Delaware to Texas by conversion. Extraordinary Transactions |
Board | For | AGAINST 1 fund |
Split 1 AGAINST, 1 ABSTAIN |
| ARCHER AVIATION INC. | June 26, 2026 | Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 1 AGAINST, 1 ABSTAIN |
| ARCHER AVIATION INC. | June 26, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Advisory Vote on Executive Compensation. Say-on-Pay |
Board | For | FOR 10 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Approval of an Amendment to the 2020 Incentive Compensation Plan. Compensation |
Board | For | FOR 7 funds |
Split 7 FOR, 2 ABSTAIN |
| ARCHER-DANIELS-MIDLAND COMPANY | May 7, 2026 | Ratification of Appointment of Ernst & Young LLP as Independent Registered Public Accounting Firm for the Year Ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 6 FOR, 1 AGAINST, 2 ABSTAIN |
| ARCHROCK, INC. | April 30, 2026 | Advisory, non-binding vote to approve the compensation provided to our Named Executive Officers for 2025. Say-on-Pay |
Board | For | FOR 4 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCHROCK, INC. | April 30, 2026 | Ratification of the appointment of Deloitte & Touche LLP as Archrock, Inc.'s independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 3 funds |
Split 3 FOR, 2 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
Split 6 FOR, 1 ABSTAIN |
| ARCOSA, INC. | May 13, 2026 | Ratification of Ernst & Young LLP as Arcosa's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 6 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of Arcus Biosciences for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ARCUTIS BIOTHERAPEUTICS, INC. | June 5, 2026 | To ratify the selection, by the Audit Committee of the Company's Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve the amendment to the Amended and Restated 2014 Equity Incentive Award Plan, or the Restated Plan, to increase the maximum number of shares of common stock that may be delivered pursuant to awards granted under the Restated Plan by 9,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
Split 1 AGAINST, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission (''Say-on-Pay''); Say-on-Pay |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| ARDELYX, INC | June 16, 2026 | To ratify the appointment, by the Audit and Compliance Committee of our Board of Directors, of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026; and Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ARES MANAGEMENT CORPORATION | June 8, 2026 | The ratification of the selection of Ernst & Young LLP as our independent registered public accounting firm for our 2026 fiscal year. Audit-related |
Board | For | FOR 10 funds |
Split 4 FOR, 2 ABSTAIN |
| ARGAN, INC. | June 10, 2026 | The ratification of the appointment of Grant Thornton LLP as our independent registered public accountants for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 2 ABSTAIN |
| ARHAUS, INC. | May 14, 2026 | To approve the selection of PricewaterhouseCoopers LLP as the Company's independent accountants for the Company's fiscal year ending December 31, 2026; Audit-related |
Board | For | FOR 1 fund |
Split 1 FOR, 1 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 20 funds |
Split 4 FOR, 5 AGAINST, 5 ABSTAIN |
| ARISTA NETWORKS, INC. | May 29, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 17 funds |
Split 9 FOR, 5 ABSTAIN |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To approve, on an advisory basis, our executive compensation program. Say-on-Pay |
Board | For | FOR 4 funds |
Split 5 FOR, 1 ABSTAIN |
| ARMSTRONG WORLD INDUSTRIES, INC. | June 11, 2026 | To ratify the selection of KPMG LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 4 funds |
Split 4 FOR, 1 AGAINST, 1 ABSTAIN |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | FOR 4 funds |
Split 2 FOR, 2 ABSTAIN |
| ARROW ELECTRONICS, INC. | May 12, 2026 | To ratify the appointment of Ernst & Young LLP as Arrow's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 2 ABSTAIN |
| ARTERIS, INC. | June 2, 2026 | To ratify the appointment by the Audit Committee of the Company's Board of Directors, of Deloitte & Touche LLP, as the independent registered public accounting firm and independent auditor for its year ending December 31, 2026; Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 1 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Approval, on an Advisory Basis, of the Compensation of our Named Executive Officers. Say-on-Pay |
Board | For | FOR 31 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| ARTHUR J. GALLAGHER & CO. | May 12, 2026 | Ratification of the Appointment of Ernst & Young LLP as our Independent Auditor for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 27 funds |
Split 4 FOR, 2 ABSTAIN |
| ARVINAS, INC. | June 24, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| ASANA, INC. | June 8, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending January 31, 2027. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
Split 5 FOR, 1 ABSTAIN |
| ASBURY AUTOMOTIVE GROUP, INC. | May 4, 2026 | Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 5 funds |
Split 5 FOR, 1 ABSTAIN |
| ASR NEDERLAND N.V | May 20, 2026 | Elect Marco Keim to Supervisory Board Director Elections |
Board | For | FOR 11 funds |
Split 2 FOR, 1 AGAINST |
| ASSA ABLOY AB | April 28, 2026 | Approve Remuneration Report Compensation |
Board | For | FOR 9 funds |
Split 2 FOR, 1 AGAINST |
| ASSA ABLOY AB | April 28, 2026 | Reelect Johan Hjertonsson (Chair), Carl Douglas (Vice Chair), Erik Ekudden, Sofia Schorling Hogberg, Lena Olving, Victoria Van Camp and Susanne Pahlen Aklundh as Directors; Elect Astrid Mozes and Jurgen Timperman as New Directors Director Elections |
Board | For | FOR 5 funds |
Split 1 FOR, 2 AGAINST |
| ASSOCIATED BANC-CORP | April 28, 2026 | Advisory approval of Associated Banc-Corp's named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSOCIATED BANC-CORP | April 28, 2026 | The ratification of the selection of KPMG LLP as the independent registered public accounting firm for Associated Banc-Corp for the year ending December 31, 2026. Audit-related |
Board | For | FOR 6 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Advisory approval of the fiscal year 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 4 funds |
Split 5 FOR, 1 AGAINST, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Approval of an amendment to the Assurant, Inc. 2017 long term equity incentive plan. Compensation |
Board | For | FOR 2 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURANT, INC. | May 21, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as Assurant's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 2 funds |
Split 6 FOR, 1 ABSTAIN |
| ASSURED GUARANTY LTD. | May 1, 2026 | Appoint PricewaterhouseCoopers LLP as the independent auditor of Assured Guaranty Re Ltd. for the fiscal year ending December 31, 2026 Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| ASSURED GUARANTY LTD. | May 1, 2026 | Appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the fiscal year ending December 31, 2026 and authorization of the Board of Directors, acting through its Audit Committee, to set the fees for the independent auditor Audit-related |
Board | For | FOR 5 funds |
Split 2 FOR, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To approve the non-binding advisory resolution on the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
Split 1 FOR, 2 AGAINST, 1 ABSTAIN |
| AST SPACEMOBILE, INC. | June 12, 2026 | To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2026. Audit-related |
Board | For | FOR 2 funds |
Split 3 FOR, 1 ABSTAIN |
| ASTERA LABS, INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers ("NEOs") as disclosed in our proxy materials. Say-on-Pay |
Board | For | FOR 2 funds |
Split 3 FOR, 1 AGAINST |
| ASTERA LABS, INC. | June 4, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 4 FOR, 2 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve the Astrana Health, Inc. Amended and Restated 2024 Equity Incentive Plan. Compensation |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To approve, on a non-binding advisory basis, the compensation program for the Company's named executive officers as disclosed in the Company's proxy statement. Say-on-Pay |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRANA HEALTH, INC. | June 10, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 2 FOR, 1 ABSTAIN |
| ASTRONICS CORPORATION | May 28, 2026 | To approve the advisory resolution indicating the approval of the Compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| AT&T INC | May 14, 2026 | Advisory approval of executive compensation Say-on-Pay |
Board | For | FOR 35 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
| AT&T INC. | May 14, 2026 | Ratification of the Appointment of Ernst & Young LLP as Independent Auditors Audit-related |
Board | For | FOR 30 funds |
Split 5 FOR, 1 AGAINST, 6 ABSTAIN |
← Previous Page 3 of 36 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.